T Cell Therapy Market Size And Share

  • Report Code : TIPRE00024331
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 138
Buy Now

T Cell Therapy Market Share, Size, and Trends by 2030

Buy Now

T Cell Therapy Market Report T Cell Therapy Market Scope and Analysis T Cell Therapy Market Size and Share

T Cell Therapy Market: Strategic Insights

T Cell Therapy Market

  • CAGR (2022 - 2030)
    16.0%
  • Market Size 2022
    US$ 2.75 Billion
  • Market Size 2030
    US$ 9.04 Billion

Market Dynamics

GROWTH DRIVERS
  • Rising cancer incidence rates globally.
  • Increased funding for immunotherapy research.
  • Growing demand for personalized medicine.
FUTURE TRENDS
  • Increased focus on CAR T-cell therapy.
  • Integration of AI in treatment development.
  • Shift towards combination therapies.
OPPORTUNITIES
  • Expansion into autoimmune disease treatments.
  • Advancements in genetic engineering technologies.
  • Collaborations with biotechnology firms.

Key Players

  • Immunocore Holdings Plc
  • Legend Biotech Corp
  • Janssen Global Services LLC
  • Gilead Sciences Inc
  • Bristol Myers Squibb Co
  • Bluebird Bio Inc
  • Novartis AG
  • JW Cayman Therapeutics Co Ltd
  • Cartesian Therapeutics Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Modality
  • Research and Commercialized
Therapy Type
  • CAR T-cell Therapy
  • T-cell Receptor-based
Indication
  • Hematologic Malignancies and Solid Tumors